Assessment of Myocardial Scar; Comparison Between 18F-FDG PET, CMR and 99Tc-Sestamibi

• Published in: Clinical Medicine Insights. Cardiology 2009-01, Vol.2009 (3), p.69
• Main Authors: Crean, Andrew, Khan, Sadia N., Davies, L. Ceri, Coulden, Richard, Dutka, David P.
• Format: Article
• Language: English
• ISSN: 1179-5468; 1179-5468
• DOI: 10.4137/CMC.S730

Andrew Crean2, Sadia N. Khan1, L. Ceri Davies1, Richard Coulden2 and David P. Dutka11Cardiovascular Medicine, Department of Medicine, University of Cambridge and 2Department of Radiology, Papworth Hospital, Papworth Everard, Cambridge, England. AbstractObjective: Patients with heart failure and ischaemic heart disease may obtain benefit from revascularisation if viable dysfunctional myocardium is present. Such patients have an increased operative risk, so it is important to ensure that viability is correctly identified. In this study, we have compared the utility of 3 imaging modalities to detect myocardial scar.Design: Prospective, descriptive study.Setting: Tertiary cardiac centre.Patients: 35 patients (29 male, average age 70 years) with coronary artery disease and symptoms of heart failure (>NYHA class II).Intervention: Assessment of myocardial scar by 99Tc-Sestamibi (MIBI), 18F-flurodeoxyglucose (FDG) and cardiac magnetic resonance (CMR).Outcome Measure: The presence or absence of scar using a 20-segment model.Results: More segments were identified as nonviable scar using MIBI than with FDG or CMR. FDG identified the least number of scar segments per patient (7.4 +/- 4.8 with MIBI vs. 4.9 +/- 4.2 with FDG vs. 5.8 +/- 5.0 with CMR, p = 0.0001 by ANOVA). The strongest agreement between modalities was in the anterior wall with the weakest agreement in the inferior wall. Overall, the agreement between modalities was moderate to good.Conclusion: There is considerable variation amongst these 3 techniques in identifying scarred myocardium in patients with coronary disease and heart failure. MIBI and CMR identify more scar than FDG. We recommend that MIBI is not used as the sole imaging modality in patients undergoing assessment of myocardial viability.